Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.
🟢 New in Current Filing
Increasing focus on environmental sustainability and social initiatives could increase our costs, and inaction could harm our reputation and adversely impact our financial results.
🔒
🔴 No Match in Current Filing
Our business and operations have been and may in the future be adversely affected by the novel coronavirus (COVID-19) pandemic.
🔒
🟡 Modified
We may be affected by healthcare reform and potential additional reforms, which may adversely impact the biopharmaceutical industry and reduce demand for our services or negatively impact our profitability.
🔒
🔴 No Match in Current Filing
If we do not keep pace with rapid technological changes, our services may become less competitive or obsolete.
🔒
🟡 Modified
The biopharmaceutical services industry is highly competitive and our business could be materially impacted if we do not compete effectively or rapidly adapt to technological change.
🔒
🟡 Modified
Our Research & Development Solutions business could subject us to potential liability that may adversely affect our results of operations and financial condition.
🔒
🟡 Modified
IT systems and Information
🔒
🟡 Modified
Market Forces
🔒
🟡 Modified
Outsourcing trends in the biopharmaceutical industry and changes in aggregate spending and research and development budgets could adversely affect our operating results and growth rate.
🔒
🟡 Modified
Risks Relating to Our Industry
🔒